Skip to main content
Erschienen in: Cellular Oncology 1/2019

26.10.2018 | Report

Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report

verfasst von: Ekjot Kaur, Jayant S. Goda, Atanu Ghorai, Sameer Salunkhe, Prakash Shetty, Aliasgar V. Moiyadi, Epari Sridhar, Abhishek Mahajan, Rakesh Jalali, Shilpee Dutt

Erschienen in: Cellular Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Previously we have shown, using a primary glioblastoma (GBM) cell model, that a subpopulation of innately radiation resistant (RR) GBM cells survive radiotherapy and form multinucleated and giant cells (MNGCs) by homotypic fusions. We also showed that MNGCs may cause relapse. Here, we set out to explore whether molecular characteristics of RR cells captured from patient-derived primary GBM cultures bear clinical relevance.

Methods

Primary cultures were derived from 19 naive GBM tumor samples. RR cells generated from these cultures were characterized using various cell biological assays. We also collected clinicopathological data of the 19 patients and assessed associations with RR variables using Spearman’s correlation test and with patient survival using Kaplan-Meier analysis. Significance was determined using a log-rank test.

Results

We found that SF2 (surviving fraction 2) values (p = 0.029), days of RR cell formation (p = 0.019) and percentage of giant cells (p = 0.034) in the RR population independently correlated with a poor patient survival. We also found that low ATM (Ataxia-telangiectasia mutated) expression levels in RR cells showed a significant (p = 0.002) negative correlation with SF2 values. A low ATM expression level in RR cells along with a high tumor volume was also found to negatively correlate with patient survival (p = 0.011). Finally, we found that the ATM expression levels in RR cells independently correlated with a poor patient survival (p = 0.014).

Conclusions

Our data indicate that molecular features of innately radiation resistant GBM cells independently correlate with clinical outcome. Our study also highlights the relevance of using patient-derived primary GBM cultures for the characterization of RR cells that are otherwise inaccessible for analysis.
Literatur
1.
3.
Zurück zum Zitat F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, C. Brennan, L. Chin, R.A. DePinho, W.K. Cavenee, Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683–2710 (2007)CrossRefPubMed F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, C. Brennan, L. Chin, R.A. DePinho, W.K. Cavenee, Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683–2710 (2007)CrossRefPubMed
4.
Zurück zum Zitat E.M. Ahmed, G. Bandopadhyay, B. Coyle, A. Grabowska, A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells. Cell Oncol 41, 319–328 (2018)CrossRef E.M. Ahmed, G. Bandopadhyay, B. Coyle, A. Grabowska, A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells. Cell Oncol 41, 319–328 (2018)CrossRef
5.
Zurück zum Zitat L.M. Nusblat, M.J. Carroll, C.M. Roth, Crosstalk between M2 macrophages and glioma stem cells. Cell Oncol 40, 471–482 (2017)CrossRef L.M. Nusblat, M.J. Carroll, C.M. Roth, Crosstalk between M2 macrophages and glioma stem cells. Cell Oncol 40, 471–482 (2017)CrossRef
6.
Zurück zum Zitat E. Kaur, J. Rajendra, S. Jadhav, E. Shridhar, J.S. Goda, A. Moiyadi, S. Dutt, Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. Carcinogenesis 36, 685–695 (2015)CrossRefPubMed E. Kaur, J. Rajendra, S. Jadhav, E. Shridhar, J.S. Goda, A. Moiyadi, S. Dutt, Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. Carcinogenesis 36, 685–695 (2015)CrossRefPubMed
7.
Zurück zum Zitat A.G. Douglas-Jones, W.T. Barr, Breast carcinoma with tumor giant cells. Report of a case with fine needle aspiration cytology. Acta Cytol 33, 109–114 (1989)PubMed A.G. Douglas-Jones, W.T. Barr, Breast carcinoma with tumor giant cells. Report of a case with fine needle aspiration cytology. Acta Cytol 33, 109–114 (1989)PubMed
8.
Zurück zum Zitat M.A. Jones, R.H. Young, R.E. Scully, Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol 10, 260–270 (1991)CrossRefPubMed M.A. Jones, R.H. Young, R.E. Scully, Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol 10, 260–270 (1991)CrossRefPubMed
9.
Zurück zum Zitat H. Kawano, T. Kubota, K. Sato, T. Goya, S. Arikawa, S. Wakisaka, Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol 14, 118–123 (1995)PubMed H. Kawano, T. Kubota, K. Sato, T. Goya, S. Arikawa, S. Wakisaka, Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol 14, 118–123 (1995)PubMed
10.
Zurück zum Zitat A.V. Parwani, M. Herawi, J.I. Epstein, Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Am J Surg Pathol 30, 1254–1259 (2006)CrossRefPubMed A.V. Parwani, M. Herawi, J.I. Epstein, Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Am J Surg Pathol 30, 1254–1259 (2006)CrossRefPubMed
11.
Zurück zum Zitat D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, P. Kleihues, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97–109 (2007)CrossRefPubMedPubMedCentral D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, P. Kleihues, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97–109 (2007)CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat N.A. Franken, H.M. Rodermond, J. Stap, J. Haveman, C. van Bree, Clonogenic assay of cells in vitro. Nat Protoc 1, 2315–2319 (2006)CrossRefPubMed N.A. Franken, H.M. Rodermond, J. Stap, J. Haveman, C. van Bree, Clonogenic assay of cells in vitro. Nat Protoc 1, 2315–2319 (2006)CrossRefPubMed
13.
Zurück zum Zitat S. Salunkhe, S.V. Mishra, J. Nair, S. Ghosh, N. Choudhary, E. Kaur, S. Shah, K. Patkar, D. Anand, N. Khattry, S.K. Hasan, S. Dutt, Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia. Int J Cancer 142, 2175–2185 (2018)CrossRefPubMed S. Salunkhe, S.V. Mishra, J. Nair, S. Ghosh, N. Choudhary, E. Kaur, S. Shah, K. Patkar, D. Anand, N. Khattry, S.K. Hasan, S. Dutt, Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia. Int J Cancer 142, 2175–2185 (2018)CrossRefPubMed
14.
Zurück zum Zitat F. Varghese, A.B. Bukhari, R. Malhotra, A. De, IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One 9, e96801 (2014)CrossRefPubMedPubMedCentral F. Varghese, A.B. Bukhari, R. Malhotra, A. De, IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One 9, e96801 (2014)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat S. Zhang, I. Mercado-Uribe, Z. Xing, B. Sun, J. Kuang, J. Liu, Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 33, 116–128 (2013)CrossRefPubMed S. Zhang, I. Mercado-Uribe, Z. Xing, B. Sun, J. Kuang, J. Liu, Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 33, 116–128 (2013)CrossRefPubMed
18.
Zurück zum Zitat J. Bartek, J. Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421–429 (2003)CrossRefPubMed J. Bartek, J. Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421–429 (2003)CrossRefPubMed
19.
Zurück zum Zitat K.A. Nyberg, R.J. Michelson, C.W. Putnam, T.A. Weinert, Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 36, 617–656 (2002)CrossRefPubMed K.A. Nyberg, R.J. Michelson, C.W. Putnam, T.A. Weinert, Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 36, 617–656 (2002)CrossRefPubMed
20.
Zurück zum Zitat S. Angèle, I. Treilleux, P. Tanière, G. Martel-Planche, M. Vuillaume, C. Bailly, A. Brémond, R. Montesano, J. Hall, Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res 6, 3536–3544 (2000)PubMed S. Angèle, I. Treilleux, P. Tanière, G. Martel-Planche, M. Vuillaume, C. Bailly, A. Brémond, R. Montesano, J. Hall, Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res 6, 3536–3544 (2000)PubMed
21.
Zurück zum Zitat T.M.A. Abdel-Fatah, A. Arora, N. Alsubhi, D. Agarwal, P.M. Moseley, C. Perry, R. Doherty, S.Y.T. Chan, A.R. Green, E. Rakha, G. Ball, I.O. Ellis, S. Madhusudan, Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts. Neoplasia 16, 982–991 (2014)CrossRefPubMedPubMedCentral T.M.A. Abdel-Fatah, A. Arora, N. Alsubhi, D. Agarwal, P.M. Moseley, C. Perry, R. Doherty, S.Y.T. Chan, A.R. Green, E. Rakha, G. Ball, I.O. Ellis, S. Madhusudan, Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts. Neoplasia 16, 982–991 (2014)CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat M. Squatrito, C.W. Brennan, K. Helmy, J.T. Huse, J.H. Petrini, E.C. Holland, Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 18, 619–629 (2010)CrossRefPubMed M. Squatrito, C.W. Brennan, K. Helmy, J.T. Huse, J.H. Petrini, E.C. Holland, Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 18, 619–629 (2010)CrossRefPubMed
23.
Zurück zum Zitat F.M. Uckun, W. Jaszcz, M. Chandan-Langlie, K.G. Waddick, K. Gajl-Peczalska, C.W. Song, Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia. J Clin Invest 91, 1044–1051 (1993)CrossRefPubMedPubMedCentral F.M. Uckun, W. Jaszcz, M. Chandan-Langlie, K.G. Waddick, K. Gajl-Peczalska, C.W. Song, Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia. J Clin Invest 91, 1044–1051 (1993)CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Q. Matthews, A. Jirasek, J.J. Lum, A.G. Brolo, Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy. Phys Med Biol 56, 6839–6855 (2011)CrossRefPubMed Q. Matthews, A. Jirasek, J.J. Lum, A.G. Brolo, Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy. Phys Med Biol 56, 6839–6855 (2011)CrossRefPubMed
25.
Zurück zum Zitat S. Tribius, A. Pidel, D. Casper, ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys 50, 511–523 (2001)CrossRefPubMed S. Tribius, A. Pidel, D. Casper, ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys 50, 511–523 (2001)CrossRefPubMed
26.
Zurück zum Zitat S. Knappskog, R. Chrisanthar, E. Lokkevik, G. Anker, B. Ostenstad, S. Lundgren, T. Risberg, I. Mjaaland, B. Leirvaag, H. Miletic, P.E. Lonning, Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer. Breast Cancer Res 14, R47 (2012)CrossRefPubMedPubMedCentral S. Knappskog, R. Chrisanthar, E. Lokkevik, G. Anker, B. Ostenstad, S. Lundgren, T. Risberg, I. Mjaaland, B. Leirvaag, H. Miletic, P.E. Lonning, Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer. Breast Cancer Res 14, R47 (2012)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat H. Jiang, H.C. Reinhardt, J. Bartkova, J. Tommiska, C. Blomqvist, H. Nevanlinna, J. Bartek, M.B. Yaffe, M.T. Hemann, The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev 23, 1895–1909 (2009)CrossRefPubMedPubMedCentral H. Jiang, H.C. Reinhardt, J. Bartkova, J. Tommiska, C. Blomqvist, H. Nevanlinna, J. Bartek, M.B. Yaffe, M.T. Hemann, The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev 23, 1895–1909 (2009)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat I. Dokic, A. Mairani, S. Brons, B. Schoell, A. Jauch, D. Krunic, J. Debus, A. Régnier-Vigouroux, K. Weber, High resistance to X-rays and therapeutic carbon ions in glioblastoma cells bearing dysfunctional ATM associates with intrinsic chromosomal instability. Int J Radiat Biol 91, 157–165 (2015)CrossRefPubMed I. Dokic, A. Mairani, S. Brons, B. Schoell, A. Jauch, D. Krunic, J. Debus, A. Régnier-Vigouroux, K. Weber, High resistance to X-rays and therapeutic carbon ions in glioblastoma cells bearing dysfunctional ATM associates with intrinsic chromosomal instability. Int J Radiat Biol 91, 157–165 (2015)CrossRefPubMed
29.
Zurück zum Zitat M.A. Haidar, H. Kantarjian, T. Manshouri, C.Y. Chang, S. O'Brien, E. Freireich, M. Keating, M. Albitar, ATM gene deletion in patients with adult acute lymphoblastic leukemia. Cancer 88, 1057–1062 (2000)CrossRefPubMed M.A. Haidar, H. Kantarjian, T. Manshouri, C.Y. Chang, S. O'Brien, E. Freireich, M. Keating, M. Albitar, ATM gene deletion in patients with adult acute lymphoblastic leukemia. Cancer 88, 1057–1062 (2000)CrossRefPubMed
30.
Zurück zum Zitat L. Ripolles, M. Ortega, F. Ortuno, A. Gonzalez, J. Losada, J. Ojanguren, J.A. Soler, J. Bergua, M.D. Coll, M.R. Caballin, Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer Genet Cytogenet 171, 57–64 (2006)CrossRefPubMed L. Ripolles, M. Ortega, F. Ortuno, A. Gonzalez, J. Losada, J. Ojanguren, J.A. Soler, J. Bergua, M.D. Coll, M.R. Caballin, Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer Genet Cytogenet 171, 57–64 (2006)CrossRefPubMed
31.
Zurück zum Zitat B. Austen, A. Skowronska, C. Baker, J.E. Powell, A. Gardiner, D. Oscier, A. Majid, M. Dyer, R. Siebert, A.M. Taylor, P.A. Moss, T. Stankovic, Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol 25, 5448–5457 (2007)CrossRefPubMed B. Austen, A. Skowronska, C. Baker, J.E. Powell, A. Gardiner, D. Oscier, A. Majid, M. Dyer, R. Siebert, A.M. Taylor, P.A. Moss, T. Stankovic, Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol 25, 5448–5457 (2007)CrossRefPubMed
32.
Zurück zum Zitat S. Rondeau, S. Vacher, L. De Koning, A. Briaux, A. Schnitzler, W. Chemlali, C. Callens, R. Lidereau, I. Bièche, ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. Br J Cancer 112, 1059–1066 (2015)CrossRefPubMedPubMedCentral S. Rondeau, S. Vacher, L. De Koning, A. Briaux, A. Schnitzler, W. Chemlali, C. Callens, R. Lidereau, I. Bièche, ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. Br J Cancer 112, 1059–1066 (2015)CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat N.S. Shabb, A. Tawil, F. Gergeos, M. Saleh, S. Azar, Multinucleated giant cells in fine-needle aspiration of thyroid nodules: Their diagnostic significance. Diagn Cytopathol 21, 307–312 (1999)CrossRefPubMed N.S. Shabb, A. Tawil, F. Gergeos, M. Saleh, S. Azar, Multinucleated giant cells in fine-needle aspiration of thyroid nodules: Their diagnostic significance. Diagn Cytopathol 21, 307–312 (1999)CrossRefPubMed
34.
Zurück zum Zitat I. Kern, P. Kecelj, M. Kosnik, M. Mermolja, Multinucleated giant cells in bronchoalveolar lavage. Acta Cytol 47, 426–430 (2003)CrossRefPubMed I. Kern, P. Kecelj, M. Kosnik, M. Mermolja, Multinucleated giant cells in bronchoalveolar lavage. Acta Cytol 47, 426–430 (2003)CrossRefPubMed
Metadaten
Titel
Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report
verfasst von
Ekjot Kaur
Jayant S. Goda
Atanu Ghorai
Sameer Salunkhe
Prakash Shetty
Aliasgar V. Moiyadi
Epari Sridhar
Abhishek Mahajan
Rakesh Jalali
Shilpee Dutt
Publikationsdatum
26.10.2018
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 1/2019
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-018-0411-7

Weitere Artikel der Ausgabe 1/2019

Cellular Oncology 1/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie